# Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints

**Authors:** Rosanne D. Reitsema, Seta Kurt, Ignacio Rangel, Hans Hjelmqvist, Mats Dreifaldt, Allan Sirsjö, Ashok Kumar Kumawat

PMC · DOI: 10.3389/fimmu.2025.1568431 · Frontiers in Immunology · 2025-07-21

## TL;DR

This study found altered immune checkpoint expression in peripheral artery disease patients, suggesting immune system changes linked to the disease.

## Contribution

The study identifies sex-specific differences in immune checkpoint expression and explores immune exhaustion in peripheral artery disease.

## Key findings

- Female PAD patients had decreased soluble PD-L2 and increased soluble TIM-3 levels.
- PAD patients showed higher PD-L2+ frequencies in monocyte subsets and increased TIM-3+ CD4+ T cells.
- TIM-3+ CD4+ T cells from PAD patients and controls produced more IL-10 and fewer pro-inflammatory cytokines.

## Abstract

Studies suggest that immune checkpoints play a role in accelerating the formation of atherosclerosis. We aimed to assess the expression of soluble and membrane-bound immune checkpoints in patients with peripheral artery disease (PAD).

The levels of 14 soluble immune checkpoints were assessed in blood plasma of PAD patients (n= 37) and healthy controls (HCs, n=39) by Multiplex protein assay. The surface expression of immune checkpoints on peripheral blood immune cells was determined by flow cytometry. Cytokine production capacity was measured by flow cytometry in TIM-3+ T cells to determine immune exhaustion.

Soluble levels of PD-L2 were decreased in female PAD patients, whereas soluble levels of TIM-3 showed a trend towards an increased concentration in female PAD patients. PD-L2+ frequencies were higher within all monocyte subsets in PAD patients. CD4+ T cells from PAD patients had increased frequencies of TIM-3+ cells, showing little overlap with other immune exhaustion markers. TIM-3+ CD4+ T cells from both PAD patients and HCs, had a low capacity to produce pro-inflammatory cytokines, but a higher capacity to produce IL-10 compared to TIM-3- CD4+ T cells.

PAD patients show differences in the expression of membrane-bound and soluble immune checkpoints. Some of these differences might be caused by prolonged immune activation, although immune exhaustion markers did not always overlap.

## Linked entities

- **Proteins:** PDCD1LG2 (programmed cell death 1 ligand 2), HAVCR2 (hepatitis A virus cellular receptor 2)
- **Diseases:** atherosclerosis (MONDO:0005311)

## Full-text entities

- **Genes:** HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}, PDCD1LG2 (programmed cell death 1 ligand 2) [NCBI Gene 80380] {aka B7DC, Btdc, CD273, PD-L2, PDCD1L2, PDL2}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}
- **Diseases:** inflammatory (MESH:D007249), PAD (MESH:D058729), atherosclerosis (MESH:D050197)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12318762/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12318762/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12318762/full.md

---
Source: https://tomesphere.com/paper/PMC12318762